Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effectiveness and Safety of the Switch from Remicade® to CT-P13 in Patients with Inflammatory Bowel Disease.
Journal of Crohn's & colitis·2019
[Cost analysis of the use of botulinum toxin type A in Spain].
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria·2014
Quantitative renal cortical perfusion in human subjects with magnetic resonance imaging using iron-oxide nanoparticles: influence of T1 shortening.
Acta radiologica (Stockholm, Sweden : 1987)·2008
Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.
Bone marrow transplantation·2003
Epidemiology of the relationship between exposure to indoor allergens and asthma.
International archives of allergy and applied immunology·1991
T cells and asthma. II. Regulation of the eosinophilia of asthma by T cell cytokines.
International archives of allergy and applied immunology·1991
T cells and asthma. I. Lymphocyte subpopulations and activation in allergic and nonallergic asthma.
International archives of allergy and applied immunology·1991
Human upper airway epithelial cell-derived granulocyte-macrophage colony-stimulating factor induces histamine-containing cell differentiation of human progenitor cells.
International archives of allergy and applied immunology·1991
Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine.
International archives of allergy and applied immunology·1991
Effects of the platelet-activating factor antagonist BN 52021 on anti-islet cytotoxicity of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
International archives of allergy and applied immunology·1991
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026